Deep Sea Rare Minerals, Inc. Receives NOAA Determination of “Substantial Compliance” Advancing Exploration License Application Process

MT. PLEASANT, SC / ACCESS Newswire / January 8, 2026 / Deep Sea Rare Minerals, Inc. (DSRM) announced today that it has received written notice of substantial compliance for its exploration license from the National Oceanic and Atmospheric Administration ("NOAA"), acting pursuant to the U.S. Deep Seabed Hard Mineral Resources Act (the "DSHMRA") and NOAA’s

Glenn Smith Executive Coaching Shares Actionable Insights to Strengthen Family-Owned Enterprises

Sugar Land, TX – Family-owned businesses across the region are being equipped with practical strategies to grow, adapt, and thrive in today’s competitive marketplace, according to the latest collection of expert-driven content from Glenn Smith Executive Coaching. As small and family-owned businesses continue to be an essential part of local commerce and community identity, Glenn’s

Arconic Corporation (ARNC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arconic Corporation ("Arconic" or "the Company") (NYSE:ARNC). Investors who purchased Arconic securities prior to April 19, 2022, and continue to hold to the present, are encouraged to obtain additional

Charter Communications, Inc. (CHTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Charter Communications, Inc. ("Charter" or "the Company") (NASDAQ:CHTR). Investors who purchased Charter securities prior to July 26, 2024, and continue to hold to the present, are encouraged to obtain

Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Investors to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:SLQT). Investors who purchased SelectQuote securities prior to September 9, 2020, and continue to hold to the present, are encouraged to obtain additional information

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against KinderCare Learning Companies, Inc. (KLC) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of KinderCare Learning Companies, Inc. ("KinderCare" or "the Company") (NYSE:KLC). Investors who purchased KinderCare securities prior to October 9, 2024, and continue to hold to the present, are encouraged to

New Era Energy & Digital, Inc. (NUAI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of New Era Energy & Digital, Inc. ("New Era" or "the Company") (NASDAQ:NUAI). Investors who purchased New Era securities are encouraged to obtain additional information and assist the investigation by

Sharecare Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional

Zenas BioPharma, Inc. (ZBIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 8, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zenas BioPharma, Inc. ("Zenas BioPharma" or "the Company") (NASDAQ:ZBIO). Investors who purchased Zenas BioPharma securities prior to September 13, 2024, and continue to hold to the present, are encouraged

Scroll to Top